Concepedia

Sheren Younes

SY

13

Publications

1.5K

Citations

12

H-Index

2010

Active since

Affiliations

Stanford University(Current)

The University of Texas MD Anderson Cancer Center

City Of Hope National Medical Center

Sylvester Comprehensive Cancer Center

Adaptive Biotechnologies (United States)

Sheren Younes is an author at Stanford University specializing in autoimmunity, immunotherapy, and medicine.

ORCID

Top concepts

Publications per year

2010–2024

13

Publications

13

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 537 citations · Full text

Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination

Katharina Röltgen, Sandra C. A. Nielsen, Oscar Silva et al. · Cell · 2022 · 473 citations · Full text

Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas

Brian J. Sworder, David M. Kurtz, Stefan Alig et al. · Cancer Cell · 2022 · 119 citations · Full text

, , +7

CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma

John H. Baird, Matthew J. Frank, Juliana Craig et al. · Blood · 2020 · 80 citations · Full text

Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse Components

Sheren Younes, Andrew H. Beck, Izidore S. Lossos et al. · The American Journal of Surgical Pathology · 2010 · 48 citations

, , +23

Rows per page

1–5 of 13